Product Images Venlafaxine Hydrochloride

Description: Venlafaxine HCI is a prescription drug in the form of an extended-release capsule with strength 150 mg. It comes in a package of 30 capsules that are repackaged by RemedyRepack Inc. in Indiana. The drug is manufactured by Teva in Frazer, PA. The medicine should be kept out of the reach of children and stored between 20-25°C, with excursions permissible to 15-30°C. Directions for use, including expiration date and other relevant information, can be found in the package insert.*

This appears to be a table of drug interactions and analyte readings, with information on PK fold change and 90% Cl recommendations. The drugs listed include Ethanol, Diazepam, Cimetidine, and Ketoconazole, among others. There also seem to be recommendations for concomitant use and cautions regarding hypertension, age, and hepatic dysfunction. However, without a clearer understanding of the context and purpose of the table, it may not be possible to provide a more specific description.*

This is a list of interacting drugs and how they affect certain analytes. It includes recommendations for whether or not to use them together, dosing adjustments, and potential side effects. The analytes listed include cmax (maximum plasma concentration) and AuC (area under the plasma concentration-time curve).*

This appears to be a medication dosing recommendation table for a specific population with varying conditions and biological factors such as liver and renal impairment, age, gender, and metabolizer type. The recommendation is to adjust the dose for the specific medication based on fold change and 90% confidence interval. However, the specific medication is not identifiable due to errors in the process.*

The text contains chemical formulae and the name of a drug, "venlafaxine hydrochloride". It is likely an excerpt from a scientific or medical paper discussing the structure, composition, or synthesis of the drug or related compounds.*